ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,208Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 49

$1.1M Total Retail Price of All Prescriptions

Rank: 5 out of 49

816 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 816 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

37% of this provider’s 816 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

3% of this provider’s 21,099 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 27.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
LEVOTHYROXINE SODIUM 2,696 2,158 1 2
HYDROCODONE-ACETAMINOPHEN 1,582 1,021 S3 2 3
LISINOPRIL 1,090 828 3 1
OMEPRAZOLE 802 581 4 5
SIMVASTATIN 776 640 5 4
AMLODIPINE BESYLATE 709 620 6 7
POTASSIUM CHLORIDE 646 493 7 9
GABAPENTIN 579 421 8 12
FUROSEMIDE 471 372 9 6
ALENDRONATE SODIUM 471 420 9 33
METFORMIN HCL 458 289 11 8
WARFARIN SODIUM 394 334 12 13
TAMSULOSIN HCL 392 354 13 26
ZOLPIDEM TARTRATE 383 218 14 19
METOPROLOL TARTRATE 342 270 15 10
METOPROLOL SUCCINATE 325 307 16 21
CITALOPRAM HBR 315 208 17 16
MELOXICAM 302 219 18 29
FENOFIBRATE 300 200 19 54
HYDROCHLOROTHIAZIDE 264 174 20 14
LOVASTATIN 261 210 21 25
CIPROFLOXACIN HCL 252 185 22 52
TRAZODONE HCL 250 155 23 28
MIRTAZAPINE 239 172 24 41
POLYETHYLENE GLYCOL 3350 235 193 25 46
ATORVASTATIN CALCIUM 232 213 26 18
ROPINIROLE HCL 228 168 27 58
ALLOPURINOL 227 171 28 37
LISINOPRIL-HYDROCHLOROTHIAZIDE 217 180 29 30
CYCLOBENZAPRINE HCL 215 101 R 30 31
ENDOCET 208 87 S2 31 70
RANITIDINE HCL 194 136 32 11
ATENOLOL 186 150 33 17
CARVEDILOL 179 120 34 24
PANTOPRAZOLE SODIUM 171 105 35 55
GLIMEPIRIDE 170 123 36 45
METFORMIN HCL ER 168 110 37 85
TRAMADOL HCL 166 95 38 15
PREDNISONE 164 124 39 42
SERTRALINE HCL 164 110 39 22
TRIAMTERENE-HCTZ 162 105 41 79
AZITHROMYCIN 158 116 42 39
LANTUS 156 115 43 44
PROAIR HFA 142 63 44 32
NEXIUM 139 91 45 23
FLUTICASONE PROPIONATE 139 94 45 43
FLUOXETINE HCL 139 73 45 60
ESTRADIOL 137 101 R 48 163
SPIRONOLACTONE 134 94 49 76
DILTIAZEM 24HR ER 131 113 50 164
CARISOPRODOL 127 57 R 51 48
CYMBALTA 125 49 52 35
CEFUROXIME 125 103 52 176
BISOPROLOL-HYDROCHLOROTHIAZIDE 123 76 54 136
OXYBUTYNIN CHLORIDE 123 88 54 101
LOSARTAN POTASSIUM 121 84 56 50
TIZANIDINE HCL 118 44 57 141
TORSEMIDE 114 81 58 133
ETODOLAC 113 36 59 167
INSULIN SYRINGE 110 82 60 143
BENAZEPRIL HCL 106 94 61 131
TRIAMTERENE-HYDROCHLOROTHIAZID 105 89 62 182
LEVOFLOXACIN 105 68 62 91
DONEPEZIL HCL 104 103 64 20
AMITRIPTYLINE HCL 102 55 R 65 59
CEPHALEXIN 101 75 66 81
DEXILANT 99 87 67 162
FAMOTIDINE 97 77 68 75
FLUCONAZOLE 97 41 68 160
RISPERIDONE 97 76 68 53
OXYBUTYNIN CHLORIDE ER 93 76 71 129
AMOXICILLIN 89 61 72 87
TRIAMCINOLONE ACETONIDE 89 72 72 144
PAROXETINE HCL 89 38 72 71
AMLODIPINE BESYLATE-BENAZEPRIL 88 65 75 150
METHADONE HCL 88 32 S2 75 173
OXYCODONE-ACETAMINOPHEN 87 20 S2 77 74
VENTOLIN HFA 86 53 78 135
DIGOXIN 85 85 79 62
SPIRIVA 85 64 79 55
SULFAMETHOXAZOLE-TRIMETHOPRIM 84 72 81 65
BUPROPION XL 83 38 82 229
CLONIDINE HCL 83 65 82 63
CELEBREX 81 60 84 78
IBUPROFEN 80 37 85 51
FLUOCINONIDE 80 77 85 232
PRAVASTATIN SODIUM 79 67 87 26
NOVOLOG 76 70 88 95
TRICOR 76 52 88 86
CLOPIDOGREL 74 52 90 40
VERAPAMIL ER 74 45 90 124
ALPRAZOLAM 71 62 92 242
DILTIAZEM 24HR CD 71 55 92 117
ISOSORBIDE MONONITRATE ER 70 60 94 57
DOXAZOSIN MESYLATE 67 67 95 171
NAPROXEN 66 31 96 68
HYDROXYZINE HCL 64 48 R 97 158
ENALAPRIL MALEATE 60 60 98 104
LYRICA 59 18 99 113
CLOTRIMAZOLE-BETAMETHASONE 59 40 99 205
PROMETHAZINE HCL 58 42 R 101 122
ADVAIR DISKUS 58 48 101 34
CRESTOR 58 53 101 36
DETROL LA 57 38 104 157
KETOCONAZOLE 57 40 104 215
TOPIRAMATE 57 0 104 118
DOXEPIN HCL 57 39 104 262
NABUMETONE 56 40 108 264
COLESTIPOL HCL 55 43 109 268
VENLAFAXINE HCL ER 55 15 109 110
PLAVIX 55 40 109 64
DILANTIN 55 30 109 195
GLIPIZIDE XL 55 39 109 198
LANTUS SOLOSTAR 54 29 114 103
EVISTA 54 43 114 270
HALOPERIDOL 51 51 116 154
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 10, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.